CollPlant Biotechnologies Ltd
Nasdaq · Healthcare · Orthopedic, Prosthetic & Surgical Appliances & Supplies · Rehovot, Israel
CLGN chart
What traders are saying about $CLGN
Latest postsCollPlant Biotechnologies Ltd news
- A 10% stockholder proposes selling 15,550 CollPlant (CLGN) shares.
Stock Titan ·
- An equity-and-warrant offering has $0 left to sell at CollPlant (CLGN).
Stock Titan ·
- COLLPLANT ANNOUNCES A $3.7 MILLION PRIVATE PLACEMENT
Yahoo Finance ·
- LightSolver Files U.S. Provisional Patent Application Expanding its Photonic Computing Platform to Advanced Scientific and Engineering Simulations
Yahoo Finance ·
- COLLPLANT REPORTS 2026 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
Yahoo Finance ·
- LightSolver, a CollPlant Company, and HLRS Joint Research Demonstrated Photonic Computing Can significantly Accelerate Fundamental HPC Workloads
Yahoo Finance ·
- CollPlant Regains Compliance with Nasdaq Minimum Bid Price Requirement
Yahoo Finance ·
- CollPlant to Host LightSolver Investor Webinar on September 17, 2026
Yahoo Finance ·
- COLLPLANT APPOINTS DR. RUTI BEN SHLOMI TO ITS BOARD OF DIRECTORS FOLLOWING CLOSING OF LIGHTSOLVER ACQUISITION
Yahoo Finance ·
- COLLPLANT COMPLETES ACQUISITION OF LIGHTSOLVER, ENTERING THE PHOTONIC COMPUTING SECTOR
Yahoo Finance ·
- COLLPLANT ANNOUNCES REVERSE SHARE SPLIT
Yahoo Finance ·
- COLLPLANT IS ACQUIRING LIGHTSOLVER- ENTERS SUPERCOMPUTING AND PHOTONIC COMPUTING MARKETS
Yahoo Finance ·
CollPlant Biotechnologies Ltd key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $2.4M | $515,000 | $11.0M | $299,000 |
| Net income | -$11.5M | -$16.6M | -$7.0M | -$16.9M |
| Diluted EPS | $-0.94 | $-1.45 | $-0.62 | $-1.53 |
| Total assets (year end) | $10.8M | $18.7M | $34.1M | $37.8M |
| Cash and equivalents (year end) | $5.6M | $11.9M | $26.7M | $29.7M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KREPORT OF FOREIGN PRIVATE ISSUER
- 6-KFORM 6-K
About CollPlant Biotechnologies Ltd
- Ticker
- CLGN (Nasdaq)
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Headquarters
- Rehovot, Israel
- Incorporated in
- Israel
- Fiscal year end
- December 31
- SEC CIK
- 1631487
- Former names
- CollPlant Biotechnologies Ltd., CollPlant Holdings Ltd.
Frequently asked questions
What exchange is CollPlant Biotechnologies Ltd listed on?
CollPlant Biotechnologies Ltd trades on the Nasdaq under the ticker symbol CLGN.
What industry is CollPlant Biotechnologies Ltd in?
CollPlant Biotechnologies Ltd is classified by the SEC under "Orthopedic, Prosthetic & Surgical Appliances & Supplies", part of the Healthcare sector on StockTweeting.
Where is CollPlant Biotechnologies Ltd headquartered?
CollPlant Biotechnologies Ltd's business address on file with the SEC is in Rehovot, Israel.
When does CollPlant Biotechnologies Ltd's fiscal year end?
CollPlant Biotechnologies Ltd's fiscal year ends on December 31.
How much revenue did CollPlant Biotechnologies Ltd report?
CollPlant Biotechnologies Ltd reported $2.4M in revenue for calendar year 2025, according to its SEC filings.